|
1. Cancer drug pulled from US market Full story
2. GLP-1 drugs tied to lower addiction risk: Study Full story
3. Inside one AMC's approach to proactive staffing across 53 ORs here.
4. Novo, Hims strike GLP-1 deal after legal feud Full story
5. FDA, states review plans to import drugs from Canada Full story
6. 2026 strategy check: Are your assumptions about care delivery still holding up? Get answers here.
7. FDA sends Novo Nordisk 2nd warning over GLP-1 ads Full story
8. Private equity invested $1 trillion in healthcare in 10 years: Report Full story
Becker's Learning Opportunities
9. Temple Health, Endeavor Health and others share oncology strategies for 2030 here.
10. Preoperative risk is often identified too late. See how leaders are catching it earlier here.
11. Cost transparency helps patients move forward with care faster. Learn why here.
12. Interested in more? See Becker’s full lineup of
webinars and
whitepapers.
Apply to attend complimentary as a guest reviewer here! Opportunity exclusive to those directly employed by a provider organization.
|
.png)
